甲状腺乳腺疾病相关性的研究进展

Abstract
Figure/Table
References (32)
Related Citation (15)

Download: PDF (647 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract The incidence of thyroid and breast diseases is increasing， thyroid and breast belong to hormone response organ. There is a clear correlation between the two diseases， thyroid disease can increase the risk of breast disease and vice versa. The same pathogenesis of them is still under study. It is clear that estrogen and thyroxine promote the occurrence and development. This paper reviews the progress of researchs concerning the role of estrogen and thyroid hormone in thyroid and breast diseases.

Key words： Thyroid disease Breast disease Thyroxine Estrogen Correlation

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHAO Yingjie1 ZHANG Hehuan2

Cite this article:

ZHAO Yingjie1 ZHANG Hehuan2. Research progress of the correlation of thyroid and breast diseases[J]. 中国医药导报, 2018, 15(32): 46-49.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2018/V15/I32/46

[1] Fan L，Strasser-Weippl K，Li JJ，et al. Breast cancer in China [J]. Lancet Oncol，2014，15（7）：e279-e289.
[2] Liu Y，Lin Z，Sheng C，et al. The prevalence of thyroid nodules in northwest China and its correlation with metabolic parameters and uric acid [J]. Oncotarget，2017，8（25）：41 555-41 562.
[3] Hardefeldt PJ，Eslick GD，Edirimanne S. Benign thyroid disease is associated with breast cancer：a meta-analysis [J]. Breast Cancer Res Treat，2012，133（3）：1169-1177.
[4] Michalaki V，Kondi-Pafiti A，Gennatas S，et al. Breast cancer in association with thyroid disorders [J]. J BUON，2009，14（3）：425-428.
[5] Giustarini E，Pinchera A，Fierabracci P，et al. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery [J]. Eur J Endoerinol，2006，154（5）：645-649.
[6] Muller I，Zhang L，Giani C，et al. The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen [J]. J Endocrinol Invest，2016，39（3）：323-331.
[7] Shi X，Jin X，Xu P，et al. Relationship between breast cancer and levels of serum thyroid hormones and antibodies：a meta-analysis [J]. Asian Pac J Cancer Prev，2014，15（16）：6643-6647.
[8] Fiore E，Giustarini E，Mammoli C，et al. Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer [J]. J Endocrinol Invest，2007，30（9）：734-738.
[9] Angelousi A，Diamanti-Kandarakis E，Zapanti E，et al. Is there an association between thyroid function abnormalities and breast cancer? [J]. Arch Endocrinol Metab，2017， 61（1）：54-61.
[10] Farahati J，Roggenbuck D，Gilman E，et al. Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer [J]. Clin Chem Lab Med，2012，50（4）：709-714.
[11] Liu Y，Lin Z，Sheng C，et al. The prevalence of thyroid nodules in northwest China and its correlation with metabolic parameters and uric acid [J]. Oncotarget，2017， 8（25）：41 555-41 562.
[12] Shi Y，li X，Ran L，et al. Study on the status of thyroid function and thyroid nodules in chinese breast cancer patients [J]. Oncotarget，2017，8（46）：80 820-80 825.
[13] Turken O，Narin Y，Demirbas S，et al.Breast cancer in association with thyroid disorders [J]. Breast cancer Res，2003，5（5）：R110-R113.
[14] Luo J，Hendryx M，Nassir R，et al. Benign breast disease and risk of thyroid cancer [J]. Cancer Causes Control，2017， 28（9）：913-920.
[15] Schonfeld SJ，Ron E，Kitahara CM，et al. Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study [J]. Cancer Epidemiol，2011，35（6）：e85-e90.
[16] Yuan MK，Chang SC，Hsu LC，et al. Mammography and the risk of thyroid and hematological cancers：a nationwide population-based study [J]. Breast J，2014，20（5）：496-501.
[17] Van Fossen VL，Wilhelm SM，Eaton JL，et al. Association of thyroid，breast and renal cell cancer：a population-based study of the prevalence of second malignancies [J]. Ann Surg Oncol，2013，20（4）：1341-1347.
[18] Kuo JH，Chabot JA，Lee JA，et al. Breast cancer in thyroid cancer survivors：an analysis of the surveillance，epidemiology，and end results-9 database [J]. Surgery，2016，159（1）：23-30.
[19] Nielsen SM，White MG，Hong S，et al. The breast-thyroid cancer link：a systematic review and meta-analysis [J]. Cancer Epidemiol Biomarkers Prev，2016，25（2）：231-238.
[20] Kuo JH，Chabot JA，Lee JA. Breast cancer in thyroid cancer survivors：an analysis of the surveillance，epidemiology，and end results-9 database [J]. Surgery，2016，159（1）：23-29.
[21] Shin HW，Jang HW，Park JY，et al. Clinico-pathologic characteristics of the primary thyroid cancer in patients with breast cancer [J]. J Korean Endocr Soc，2009，24（4）：240-246.
[22] Rajoria S，Suriano R，Shanmugam A，et al. Metastatic phenotype is regulated by estrogen in thyroid cells [J]. Thyroid，2010，20（1）：33-41.
[23] Tan W，Li Q，Chen K，et al. Estrogen receptor beta as a prognostic factor in breast cancer patients：A systematic review and meta-analysis [J]. Oncotarget，2016，7（9）：10 373-10 385.
[24] Zhang L，Wu Y，Liu F，et al. Characteristics and survival of patients with metachronous or synchronous double primary malignancies：breast and thyroid cancer [J]. Oncotarget，2016，7（32）：52 450-52 459.
[25] Teng CJ，Hu YW，Chen SC，et al. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy：A Nationwide Population-Based Study [J]. J Natl Cancer Inst，2015，108（2）：djv314.
[26] Santin AP，Furlanetto TW. Role of estrogen in thyroid function and growth regulation [J]. J Thyroid Res，2011：875 125.
[27] Rasool M，Naseer MI，Zaigham K，et al. Comparative Study of Alterations in Triiodothyronine（T3）and Thyroxine（T4）Hormone Levels in Breast and Ovarian Cancer [J]. Pak J Med Sci，2014，30（6）：1356-1360.
[28] Hall LC，Salazar EP，Kane SR，et al. Effects of thyroid hormones on human breast cancer cell proliferation [J]. J Steroid Biochem Mol Biol，2008，109（1/2）：57-66.
[29] Dinda S，Sanchez A，Moudgil V. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins，p53 and retinoblastoma，in breast cancer cells [J]. Oncogene，2002，21（5）：761-768.
[30] Charalampoudis P，Agrogiannis G，Kontzoglou K，et al. Thyroid hormone receptor alpha（TRa）tissue expression in ductal invasive breast cancer：a study combining quantitative immunohistochemistry with digital slide image analysis [J]. EJSO，2017，8（43）：1428-1432.
[31] Tosovic A，Bondeson AG，Bondeson L，et al. Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women [J]. Breast Cancer Research，2010，12（3）：R33.
[32] Flamini MI，Uzair ID，Pennacchio GE，et al. Thyroid hormone controls breast cancer cell movement via integrin αV/β3/SRC/FAK/PI3-Kinases [J]. Horm Cancer，2017，8（1）：16-27.